Thomas V Saliga

Title: Thomas V Saliga: Innovator in Biosignal Acquisition Technology

Introduction

Thomas V Saliga is a notable inventor based in Odessa, Florida, with a remarkable portfolio of eight patents. His work primarily focuses on methods and apparatuses that enhance the acquisition of biosignals, particularly in environments with high-frequency interference.

Latest Patents

Saliga's latest patents include an "Apparatus for acquiring biosignals in the presence of HF interference" and a "Method and system for acquiring biosignals in the presence of HF interference." Both inventions aim to significantly limit the effects of high-frequency interferences on electro-physiological signals, such as EEG and EMG. The innovative approach involves two separate electronic circuitries designed to process signals effectively. One circuit blocks the transmission of HF interferences to instrumentation amplifiers, utilizing a front-end active filter, a low-frequency electromagnetic interference (EMI) shield, and an isolation barrier interface. The second circuit measures the potential difference between the two isolated sides of the isolation barrier, confirming that the acquired signals remain uncorrupted by interference.

Career Highlights

Throughout his career, Saliga has contributed to various companies, including Neurowave Systems Inc. and 516 Holdings. His expertise in biosignal technology has positioned him as a key player in the field, driving advancements that improve the reliability of medical signal acquisition.

Collaborations

Saliga has worked alongside talented individuals such as Tatjana Zikov and Stéphane Bibian, contributing to the development of innovative solutions in biosignal processing.

Conclusion

Thomas V Saliga's contributions to the field of biosignal acquisition technology demonstrate his commitment to innovation and excellence. His patents reflect a deep understanding of the challenges posed by high-frequency interference, paving the way for more reliable medical diagnostics.